Rodman & Renshaw Starts Atossa Genetics (ATOS) at Buy

July 7, 2026 7:50 AM

Rodman & Renshaw analyst Michael King Jr. initiates coverage on Atossa Genetics (NASDAQ: ATOS) with a Buy rating and a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found